Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INSULIN - ANVISA Registration 82444370226

Access comprehensive regulatory information for INSULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370226 and manufactured by MACCURA BIOTECHNOLOGY CO LTD. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82444370226
Registration Details
ANVISA Registration Number: 82444370226
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Insulin Chemiluminescent Immunoassay Kit
Risk Class II

Registration Details

82444370226

25351031251202543

07214566000165

Company Information

China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

Apr 28, 2025

VIGENTE

09/18/2025 19:00:01